 Mary Allen
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 4 | 2025 | 534 | 1.620 |
Why?
| | Transcription, Genetic | 11 | 2025 | 1496 | 1.520 |
Why?
| | Heat-Shock Response | 2 | 2024 | 78 | 0.940 |
Why?
| | AIDS Vaccines | 3 | 2025 | 52 | 0.630 |
Why?
| | Transcription Factors | 7 | 2025 | 1741 | 0.590 |
Why?
| | Cyclin-Dependent Kinases | 4 | 2025 | 123 | 0.550 |
Why?
| | Receptors, Glucocorticoid | 3 | 2023 | 138 | 0.490 |
Why?
| | Caenorhabditis elegans | 4 | 2019 | 337 | 0.480 |
Why?
| | HIV Antibodies | 3 | 2025 | 60 | 0.480 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 529 | 0.470 |
Why?
| | RNA | 7 | 2025 | 940 | 0.450 |
Why?
| | HIV-1 | 4 | 2025 | 896 | 0.440 |
Why?
| | Vaccines, DNA | 2 | 2024 | 31 | 0.420 |
Why?
| | Trans-Splicing | 2 | 2010 | 12 | 0.410 |
Why?
| | RNA Polymerase II | 6 | 2025 | 351 | 0.410 |
Why?
| | Enhancer Elements, Genetic | 4 | 2025 | 192 | 0.390 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 318 | 0.370 |
Why?
| | Transcription Factor TFIIH | 2 | 2025 | 40 | 0.340 |
Why?
| | Dexamethasone | 3 | 2023 | 372 | 0.330 |
Why?
| | Gene Expression Regulation | 6 | 2025 | 2608 | 0.320 |
Why?
| | Chromatin | 4 | 2024 | 561 | 0.320 |
Why?
| | Cyclin-Dependent Kinase 8 | 2 | 2025 | 50 | 0.310 |
Why?
| | DNA | 3 | 2024 | 1463 | 0.280 |
Why?
| | Cell Line | 4 | 2025 | 2882 | 0.270 |
Why?
| | Cell Nucleus | 2 | 2023 | 618 | 0.270 |
Why?
| | RNA, Messenger | 3 | 2025 | 2832 | 0.260 |
Why?
| | Macrophages | 3 | 2024 | 1511 | 0.240 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2025 | 14 | 0.230 |
Why?
| | Antibodies, Neutralizing | 2 | 2025 | 340 | 0.230 |
Why?
| | Preoptic Area | 1 | 2025 | 8 | 0.230 |
Why?
| | Transcription Termination, Genetic | 1 | 2025 | 23 | 0.220 |
Why?
| | Housing, Animal | 1 | 2025 | 46 | 0.220 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2024 | 10 | 0.220 |
Why?
| | Sexual Behavior, Animal | 1 | 2025 | 57 | 0.210 |
Why?
| | RNA Precursors | 3 | 2010 | 156 | 0.210 |
Why?
| | Protein Multimerization | 1 | 2025 | 213 | 0.210 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2024 | 109 | 0.210 |
Why?
| | Dosage Compensation, Genetic | 1 | 2023 | 11 | 0.200 |
Why?
| | Boidae | 1 | 2024 | 29 | 0.200 |
Why?
| | Zinc | 2 | 2024 | 295 | 0.200 |
Why?
| | Virology | 1 | 2024 | 36 | 0.200 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 40 | 0.200 |
Why?
| | X Chromosome | 1 | 2023 | 67 | 0.200 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 30 | 0.200 |
Why?
| | Interferons | 1 | 2025 | 188 | 0.200 |
Why?
| | Reproduction | 1 | 2025 | 207 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2025 | 212 | 0.200 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2023 | 42 | 0.200 |
Why?
| | Molecular Sequence Annotation | 2 | 2016 | 105 | 0.200 |
Why?
| | Dengue Virus | 1 | 2024 | 58 | 0.200 |
Why?
| | Cardiomegaly | 1 | 2024 | 174 | 0.190 |
Why?
| | Binding Sites | 4 | 2024 | 1329 | 0.190 |
Why?
| | Models, Biological | 2 | 2024 | 1821 | 0.190 |
Why?
| | Models, Genetic | 1 | 2025 | 536 | 0.180 |
Why?
| | Genomic Library | 1 | 2022 | 17 | 0.180 |
Why?
| | Hematopoiesis | 1 | 2023 | 194 | 0.180 |
Why?
| | Gene Expression Profiling | 3 | 2024 | 1782 | 0.180 |
Why?
| | Carcinogenesis | 1 | 2023 | 229 | 0.170 |
Why?
| | Salmonella Infections, Animal | 1 | 2021 | 39 | 0.170 |
Why?
| | RNA, Spliced Leader | 2 | 2010 | 12 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 276 | 0.160 |
Why?
| | HIV Infections | 3 | 2025 | 3154 | 0.160 |
Why?
| | Metals | 1 | 2021 | 142 | 0.160 |
Why?
| | Humans | 23 | 2025 | 144759 | 0.160 |
Why?
| | Protein Binding | 2 | 2024 | 2273 | 0.160 |
Why?
| | Vaccination | 2 | 2025 | 1423 | 0.150 |
Why?
| | Software | 1 | 2025 | 690 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 684 | 0.150 |
Why?
| | RNA, Helminth | 1 | 2019 | 18 | 0.150 |
Why?
| | Fibroblasts | 2 | 2024 | 1034 | 0.150 |
Why?
| | Peptide Hydrolases | 1 | 2020 | 105 | 0.150 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 56 | 0.140 |
Why?
| | Stem Cells | 1 | 2023 | 626 | 0.140 |
Why?
| | Dengue | 1 | 2020 | 89 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 969 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 549 | 0.140 |
Why?
| | Sequence Analysis, DNA | 2 | 2018 | 824 | 0.130 |
Why?
| | Mycobacterium | 1 | 2019 | 116 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2025 | 2496 | 0.130 |
Why?
| | Computational Biology | 3 | 2020 | 680 | 0.120 |
Why?
| | Transcriptome | 1 | 2023 | 1045 | 0.120 |
Why?
| | Databases, Genetic | 3 | 2025 | 248 | 0.120 |
Why?
| | Promoter Regions, Genetic | 3 | 2024 | 1257 | 0.120 |
Why?
| | Animals | 13 | 2025 | 38058 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 474 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1217 | 0.110 |
Why?
| | Immunogenicity, Vaccine | 2 | 2024 | 36 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 66 | 0.100 |
Why?
| | Operon | 2 | 2010 | 69 | 0.100 |
Why?
| | Signal Transduction | 2 | 2025 | 5226 | 0.100 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 442 | 0.100 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 24 | 0.100 |
Why?
| | Mediator Complex | 1 | 2013 | 61 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2013 | 247 | 0.090 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2019 | 210 | 0.090 |
Why?
| | Inflammation | 2 | 2019 | 2878 | 0.080 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 297 | 0.080 |
Why?
| | DNA, Intergenic | 1 | 2010 | 29 | 0.080 |
Why?
| | RNA Splice Sites | 1 | 2010 | 50 | 0.080 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2010 | 22 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2019 | 1152 | 0.080 |
Why?
| | Male | 7 | 2025 | 72315 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2024 | 2029 | 0.070 |
Why?
| | Gene Deletion | 1 | 2010 | 389 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2023 | 535 | 0.070 |
Why?
| | RNA 3' End Processing | 1 | 2008 | 11 | 0.070 |
Why?
| | RNA-Binding Proteins | 3 | 2019 | 462 | 0.070 |
Why?
| | Algorithms | 1 | 2016 | 1837 | 0.070 |
Why?
| | Gene Expression | 2 | 2023 | 1490 | 0.060 |
Why?
| | Female | 6 | 2025 | 78271 | 0.060 |
Why?
| | Phosphorylation | 2 | 2025 | 1732 | 0.060 |
Why?
| | RNA, Catalytic | 1 | 2008 | 189 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5992 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2430 | 0.060 |
Why?
| | Telomerase | 1 | 2008 | 248 | 0.060 |
Why?
| | Transcription Initiation, Genetic | 1 | 2025 | 20 | 0.060 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2025 | 63 | 0.050 |
Why?
| | Mice | 4 | 2025 | 18339 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2024 | 2050 | 0.050 |
Why?
| | Organ Specificity | 1 | 2025 | 312 | 0.050 |
Why?
| | Myofibrils | 1 | 2024 | 49 | 0.050 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2024 | 55 | 0.050 |
Why?
| | Viral Tropism | 1 | 2024 | 36 | 0.050 |
Why?
| | Immunization, Secondary | 1 | 2024 | 91 | 0.050 |
Why?
| | Pan troglodytes | 1 | 2024 | 63 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 222 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 118 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2025 | 433 | 0.050 |
Why?
| | Cell Cycle | 1 | 2025 | 596 | 0.040 |
Why?
| | Quality Control | 1 | 2022 | 163 | 0.040 |
Why?
| | Kinetics | 1 | 2025 | 1627 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 383 | 0.040 |
Why?
| | Monocytes | 1 | 2024 | 538 | 0.040 |
Why?
| | Virus Replication | 1 | 2024 | 529 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 570 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2024 | 1173 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2021 | 143 | 0.040 |
Why?
| | Salmonella typhimurium | 1 | 2021 | 190 | 0.040 |
Why?
| | Viral Nonstructural Proteins | 1 | 2020 | 67 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 86 | 0.040 |
Why?
| | Myocardium | 1 | 2024 | 939 | 0.040 |
Why?
| | Swine | 1 | 2021 | 833 | 0.030 |
Why?
| | Calcium | 1 | 2024 | 1183 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2018 | 36 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 371 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 35875 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2021 | 316 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3540 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1129 | 0.030 |
Why?
| | Neoplasms | 1 | 2013 | 2875 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2145 | 0.030 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2017 | 29 | 0.030 |
Why?
| | Disease | 1 | 2018 | 98 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 14105 | 0.030 |
Why?
| | Adult | 3 | 2025 | 40449 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2021 | 553 | 0.030 |
Why?
| | Microglia | 1 | 2019 | 268 | 0.030 |
Why?
| | Soil Microbiology | 1 | 2019 | 218 | 0.030 |
Why?
| | Genes, Lethal | 1 | 2016 | 30 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1253 | 0.030 |
Why?
| | Colitis | 1 | 2019 | 280 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1982 | 0.030 |
Why?
| | Neurons | 1 | 2025 | 1640 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 661 | 0.030 |
Why?
| | Fear | 1 | 2019 | 366 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 863 | 0.030 |
Why?
| | Markov Chains | 1 | 2016 | 129 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 236 | 0.030 |
Why?
| | Genome | 1 | 2016 | 306 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1795 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 252 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4271 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Anxiety | 1 | 2019 | 1109 | 0.020 |
Why?
| | HeLa Cells | 1 | 2013 | 650 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1025 | 0.020 |
Why?
| | Inverted Repeat Sequences | 1 | 2010 | 18 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2010 | 74 | 0.020 |
Why?
| | Uridine | 1 | 2010 | 30 | 0.020 |
Why?
| | Cleavage Stimulation Factor | 1 | 2008 | 4 | 0.020 |
Why?
| | Terminator Regions, Genetic | 1 | 2008 | 13 | 0.020 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2008 | 10 | 0.020 |
Why?
| | Histones | 1 | 2013 | 669 | 0.020 |
Why?
| | History, 21st Century | 1 | 2008 | 219 | 0.020 |
Why?
| | Nucleic Acids | 1 | 2008 | 72 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 4089 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2190 | 0.020 |
Why?
| | History, 20th Century | 1 | 2008 | 325 | 0.020 |
Why?
| | United States | 1 | 2024 | 15966 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2008 | 247 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22428 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|